August 28, 2016 8:24 AM ET

Pharmaceuticals

Company Overview of Claris Lifesciences Limited

Company Overview

Claris Lifesciences Limited, together with its subsidiaries, manufactures and sells drugs and pharmaceuticals worldwide. The company manufactures and markets products for anesthesia and analgesics, blood products, anti-infectives, plasma volume expanders, critical care, and nephrology areas, as well as for infusion therapy and nutrition applications. It also provides dialysis and transplant range across systems, solutions, medicines, disposables, and equipment. In addition, the company offers injectables for various therapeutic groups, including anti-emetics, CNS, cardiology, anti-malaria, haematinics, etc. It offers its products through various delivery systems, such as glass and plastic bo...

Near Parimal Railway Crossing

Ellisbridge

Ahmedabad,  380006

India

Founded in 1994

1,324 Employees

Phone:

91 79 2656 3331

Fax:

91 79 2640 8053

Key Executives for Claris Lifesciences Limited

Vice Chairman, Managing Director, Member of Share Transfer Committee, Member of Executive Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders Relationship Committee
Age: 36
Total Annual Compensation: 6.0M
Chief Financial Officer, Whole Time Director, Member of Share Transfer Committee, Member of Executive Committee, Member of Audit Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders Relationship Committee
Age: 42
Total Annual Compensation: 9.7M
Senior Vice President, Compliance Officer and Company Secretary
Total Annual Compensation: 8.5M
Whole Time Director, Chairman of Executive Committee, Member of Share Transfer Committee and Member of Corporate Social Responsibility Committee
Age: 63
Compensation as of Fiscal Year 2016.

Claris Lifesciences Limited Key Developments

Carlyle Group Reportedly Prepares Bid For Claris Lifesciences's Injectable Drugs Business

The Carlyle Group LP (NasdaqGS:CG) to bid for injectable drugs business of Claris Lifesciences Limited (BSE:533288). Carlyle Group to partner with a drug maker to acquire Claris's business that is valued at $400-450 million. Claris has hired Jefferies LLC and Credit Suisse Group AG (SWX:CSGN) to find a buyer for the business.

Claris Lifesciences Limited Reports Un-Audited Standalone and Consolidated Earnings Results for the First Quarter Ended June 30, 2016

Claris Lifesciences Limited reported un-audited standalone and consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, on standalone basis, the company reported total income from operations (net) of INR 290.165 million compared to INR 1,407.419 million, loss from operations before other income, finance costs and exceptional items of INR 98.977 million compared to INR 40.647 million, profit from ordinary activities before tax of INR 51.569 million compared to INR 51.622 million and net profit of INR 39.815 million or INR 0.73 per basic and diluted share compared to INR 43.707 million or INR 0.80 per basic and diluted share for the last year. For the quarter, on consolidated basis, the company reported total income from operations (net) of INR 1,998.322 million compared to INR 1,870.788 million, profit from operations before other income, finance costs and exceptional items of INR 332.644 million compared to INR 357.624 million, profit from ordinary activities before tax of INR 360.925 million compared to INR 339.596 million and net profit of INR 245.123 million or INR 4.03 per basic and diluted share compared to INR 212.814 million or INR 3.53 per basic and diluted share for the last year.

Claris Lifesciences Limited to Report Q1, 2017 Results on Aug 19, 2016

Claris Lifesciences Limited announced that they will report Q1, 2017 results on Aug 19, 2016

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Claris Lifesciences Limited, please visit www.clarislifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.